Cite
CyberKnife Xsight versus fiducial-based target-tracking: a novel 3D dosimetric comparison in a dynamic phantom.
MLA
Klein, Thomas J., et al. “CyberKnife Xsight versus Fiducial-Based Target-Tracking: A Novel 3D Dosimetric Comparison in a Dynamic Phantom.” Radiation Oncology, vol. 17, no. 1, Sept. 2022, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s13014-022-02123-1.
APA
Klein, T. J., Gill, S., Ebert, M. A., Grogan, G., Smith, W., Alkhatib, Z., Geraghty, J., Scott, A. J. D., Brown, A., & Rowshanfarzad, P. (2022). CyberKnife Xsight versus fiducial-based target-tracking: a novel 3D dosimetric comparison in a dynamic phantom. Radiation Oncology, 17(1), 1–11. https://doi.org/10.1186/s13014-022-02123-1
Chicago
Klein, Thomas J., Suki Gill, Martin A. Ebert, Garry Grogan, Warwick Smith, Zaid Alkhatib, John Geraghty, Alison J. D. Scott, Alan Brown, and Pejman Rowshanfarzad. 2022. “CyberKnife Xsight versus Fiducial-Based Target-Tracking: A Novel 3D Dosimetric Comparison in a Dynamic Phantom.” Radiation Oncology 17 (1): 1–11. doi:10.1186/s13014-022-02123-1.